Stay updated on NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial
Sign up to get notified when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.
Latest updates to the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page
- Check2 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check24 days agoChange DetectedThe website has added a new contact for intervention, Joseph Treat, MD, along with an updated version to v2.14.0, while the previous type of intervention has been removed in the revision from v2.13.3.SummaryDifference0.4%
- Check53 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check60 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information on who can answer questions about joining the study and where it is taking place, while removing the previous wording about those conducting the study.SummaryDifference2%
- Check74 days agoChange DetectedThe website has added new features for user interaction, while several detailed data fields and options for downloading study information have been removed.SummaryDifference3%
Stay in the know with updates to NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.